1. Home
  2. ESLT vs INSM Comparison

ESLT vs INSM Comparison

Compare ESLT & INSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Elbit Systems Ltd.

ESLT

Elbit Systems Ltd.

HOLD

Current Price

$766.80

Market Cap

31.4B

Sector

Industrials

ML Signal

HOLD

Logo Insmed Incorporated

INSM

Insmed Incorporated

HOLD

Current Price

$149.69

Market Cap

35.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ESLT
INSM
Founded
1966
1988
Country
Israel
United States
Employees
N/A
N/A
Industry
Military/Government/Technical
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
31.4B
35.2B
IPO Year
2002
2000

Fundamental Metrics

Financial Performance
Metric
ESLT
INSM
Price
$766.80
$149.69
Analyst Decision
Buy
Strong Buy
Analyst Count
3
23
Target Price
$550.33
$188.73
AVG Volume (30 Days)
123.9K
2.1M
Earning Date
01-01-0001
05-21-2026
Dividend Yield
0.35%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$17.91
$130.70
Revenue Next Year
$9.55
$74.05
P/E Ratio
$71.88
N/A
Revenue Growth
N/A
N/A
52 Week Low
$328.32
$60.40
52 Week High
$775.99
$212.75

Technical Indicators

Market Signals
Indicator
ESLT
INSM
Relative Strength Index (RSI) 69.66 41.80
Support Level $456.48 $139.81
Resistance Level N/A $167.01
Average True Range (ATR) 23.07 6.83
MACD 5.29 0.61
Stochastic Oscillator 92.87 27.83

Price Performance

Historical Comparison
ESLT
INSM

About ESLT Elbit Systems Ltd.

Elbit Systems Ltd is a technology company involved in producing a portfolio of systems and products for aircraft, land, and naval applications. The company's products are used for defense, homeland security, and commercial flight capabilities. Its systems and solutions may be installed on new platforms, or it may perform a comprehensive modernization program to transform a platform. Elbit Systems gives instructions to its customers on the proper maintenance of its products and will provide support team specialists when the customer cannot fix a problem. The company markets its systems and products as a prime contractor or as a subcontractor to government, defense, and homeland security contractors world wide.

About INSM Insmed Incorporated

Insmed Inc is a biopharmaceutical company. Its commercial portfolio and clinical pipeline are organized around three therapeutic areas: Respiratory, Immunology and Inflammation, and Neuro and Other Rare. The company's two commercial products, Arikayce and Brinsupri, are both part of the Respiratory therapeutic area. The firm's clinical-stage programs are TPIP, INS1148, brensocatib, and INS1201, focusing on different therapeutic areas. Additionally, Insmed's pre-clinical research programs encompass various technologies and modalities, including gene therapy, AI-driven protein engineering, protein manufacturing, RNA end-joining, and synthetic rescue. Geographically, the company generates maximum revenue from the United States from the sale of its commercial products.

Share on Social Networks: